Company

Ryght, Inc.

Ryght uses AI to help sponsors and CROs select and assess clinical trial sites.

About

Ryght's AI platform helps biopharmaceutical sponsors and contract research organizations identify and activate clinical research sites. Its AI Site Twins represent site operations and historical performance. Founded in 2023, it is based in Anaheim, US, and raised USD 3.000 mn in Seed funding in June 2025, led by Foothill Ventures with AIX Ventures and Iaso Ventures participating.

2Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in